Comparative Pharmacology
Head-to-head clinical analysis: AMILORIDE HYDROCHLORIDE versus TRIAMTERENE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMILORIDE HYDROCHLORIDE versus TRIAMTERENE.
AMILORIDE HYDROCHLORIDE vs TRIAMTERENE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amiloride hydrochloride is a potassium-sparing diuretic that blocks epithelial sodium channels (ENaC) in the distal convoluted tubule and collecting duct of the nephron, inhibiting sodium reabsorption and reducing potassium and hydrogen ion secretion.
Triamterene is a potassium-sparing diuretic that inhibits epithelial sodium channels (ENaC) in the distal convoluted tubule and collecting duct of the nephron, reducing sodium reabsorption and potassium excretion.
5-10 mg orally once daily; maximum 20 mg/day.
100-300 mg orally once daily; maximum 300 mg/day.
None Documented
None Documented
Terminal elimination half-life is 6-9 hours; prolonged to 20-24 hours in renal impairment
Clinical Note
moderateTriamterene + Digoxin
"The therapeutic efficacy of Digoxin can be decreased when used in combination with Triamterene."
Clinical Note
moderateTriamterene + Digitoxin
"The therapeutic efficacy of Digitoxin can be decreased when used in combination with Triamterene."
Clinical Note
moderateTriamterene + Deslanoside
"The therapeutic efficacy of Deslanoside can be decreased when used in combination with Triamterene."
Clinical Note
moderateTriamterene + Acetyldigitoxin
Terminal elimination half-life is approximately 1.5 to 2 hours. However, in patients with hepatic cirrhosis, half-life may be prolonged up to 4 hours; in renal impairment, half-life can extend significantly (up to 10 hours) due to reduced renal clearance.
Renal, approximately 50% unchanged; minor biliary/fecal elimination (<10%)
Approximately 50% of an oral dose is excreted unchanged in urine; about 20% is excreted as metabolites (mainly hydroxytriamterene sulfate conjugate) in urine; biliary/fecal excretion accounts for less than 10%.
Category C
Category A/B
Potassium-Sparing Diuretic
Potassium-Sparing Diuretic
"The therapeutic efficacy of Acetyldigitoxin can be decreased when used in combination with Triamterene."